NCT06475989 2026-03-02Study of Targeted Therapy vs. Chemotherapy in Patients With Thyroid CancerEastern Cooperative Oncology GroupPhase 3 Recruiting264 enrolled
NCT03690388 2025-09-25A Study of Cabozantinib Compared With Placebo in Subjects With Radioiodine-refractory Differentiated Thyroid Cancer Who Have Progressed After Prior Vascular Endothelial Growth Factor Receptor (VEGFR) -Targeted TherapyExelixisPhase 3 Active not recruiting187 enrolled 13 charts 1 FDA